Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sequential targeting dual-responsive magnetic nanoparticle for improved therapy of lung metastatic breast cancer

Published:2023-06-07 Issue:6 Volume:31 Page:655-669
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Shi Shan¹²,Cao Meiting¹,Li Yang¹,Zhou Liping¹,Zhang Shurong¹,Wang Xiaoyue¹,Xin Juan¹³,Li Wei¹³^ORCID

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University, Chongqing, PR China

2. Chengdu Seventh People’s Hospital, Chengdu, Sichuan, PR China

3. Chongqing Research Center for Pharmaceutical Engineering, Chongqing Medical University, Chongqing, PR China

Funder

the Municipal Science and Technology Committee of Chongqing

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2023.2217699

Reference75 articles.

1. Cancer Statistics, 2021

2. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets

3. Management of lymph node metastasis via local chemotherapy can prevent distant metastasis and improve survival in mice

4. Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer;Deepak KGK;Pharmaco Res,2020

5. Role of the lymphatics in cancer metastasis and chemotherapy applications

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

2. Nanotechnology for the theranostic opportunity of breast cancer lung metastasis: recent advancements and future challenges;Frontiers in Bioengineering and Biotechnology;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3